WASHINGTON, Nov. 20 (UPI) -- One year after more than 60 died and 750 were sickened by fungal meningitis, the U.S. Senate passed a law to help ensure compound drug safety, officials say.
Read more: http://www.upi.com/Health_News/2013/11/20/Bipartisan-law-to-improve-compounded-drug-safety/UPI-78551384929830/#ixzz2lDUOu9y0
The Drug Quality and Security Act reflects a bipartisan, bicameral effort to address drug safety and security issues and is aimed at helping prevent a future public health crisis such as last year's meningitis outbreak tied to the New England Compounding Center.
Sen. Tom Harkin, D-Iowa, chairman of the Senate Health, Education, Labor and Pensions Committee, said the bill cleared both houses of Congress and will go on to President Barack Obama to be signed into law.
"Just over one year ago, a widespread fungal meningitis outbreak brought attention to the legal and regulatory gaps that allowed owners and managers at the New England Compounding Center to disregard basic procedures to ensure that the products they were manufacturing were sterile. This gross negligence had heartbreaking consequences for families nationwide," Harkin said in a statement.
Read more: http://www.upi.com/Health_News/2013/11/20/Bipartisan-law-to-improve-compounded-drug-safety/UPI-78551384929830/#ixzz2lDUOu9y0
No comments:
Post a Comment